Swedish national Conference on Advanced Therapy Medicinal Products

Swedish national Conference on Advanced Therapy Medicinal Products
Evenemanget har utgått

Learn about advances in research and development of advanced therapy medicinal products and take the opportunity to make new contacts within the Swedish ATMP community.

Centre for Advanced Medical Products (CAMP), Swelife and Medicon Village cordially invites you to the first Swedish national conference on Advanced Therapy Medicinal Products (ATMP).

Who should attend? Students, academic researchers, health care representatives, industry and other stakeholders active in the ATMP area and interested in learning about advances in the Swedish ATMP scene and sharing their knowledge and experiences.

And why? This conference will provide insights into ongoing academic research, clinical applications and industrial activities in the field. Take the chance to meet potential collaborators and learn more about national initiatives around ATMP!


Participation at the conference is free of charge. Advance registration is mandatory. The number of attendants is limited to 150.

Please register here.

Program at a glance:

09.00 - 10.00 Registration and Coffee

10.00 - 10.10 Welcome and Introduction (Moderator: Mikael Wiberg)

Welcome address
Kerstin Jakobsson, Executive Vice President, Medicon Village Science Park Peter Nordström, Programme Director, Swelife

Introduction to Centre for Advanced Medical Products (CAMP)
Mikael Wiberg, Chairman, Centre for Advanced Medical Products

10.10 - 10.45 Keynote Lecture

Engineering Industrial Scale Manufacture of ATMPs in a Small Academic GMP Facility
Mark Lowdell, Director of Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital, Professor of Cell & Tissue Therapy, University College London, United Kingdom

10.45 - 12.00 Translational ATMP projects in Sweden (Chair: Anders Lindahl)

CD19 Targeting 3rd Generation CAR T cells for Refractory B Cell Malignancy
Gunilla Enblad, Professor, Uppsala University

Adoptive T cell Transfer Combined with DC Vaccination in Patients with Metastatic Melanoma
Stina Wickström, Assistant Professor, Karolinska Institute

Natural Killer Cell-based Immunotherapy for High-risk Myeloid Diseases
Andreas Björklund, Assistant Professor, Karolinska Institute

Stem Cells, no Longer Lost in Translation
Malin Parmar, Professor, Lund University

Establishment of GMP Embryonic Stem Cells for the Use in Regenerative Medicine
Fredrik Lanner, Assistant Professor, Karolinska Institute

12.00 - 13.00 Lunch

13.00 - 14.00 Translational ATMP projects in Sweden, continued (Chair: Pontus Blomberg)

Keratinocytes in Burn Care, an ATMP: Past, Present and Future
Alexandra Karström, Uppsala University Hospital

Reconstructed Tissues for Female Fertility Treatments
Mats Hellström, Assistant Professor, University of Gothenburg

Boost Brittle Bones before Birth (BOOSTB4)
Cecilia Götherström, Associate Professor, Karolinska Institute

From Cultured Cells to ATMP in Cartilage Regeneration
Anders Lindahl, Professor, University of Gothenburg

14.00 - 14.10 Short Break

14.10 - 15.30 Commercialization of ATMP in Sweden (Chair: Agneta Edberg)

AstraZeneca R&D in Cell and Gene Therapy
Anna Sandström, Science Policy and Relations Director Europe, AstraZeneca

Epithelial Cell Sheets for Esophageal Regeneration
Camilla Huse-Bondesson, CellSeed Sweden AB

Development of Tolerogenic Cell Therapy using Dendritic Cells
Anette Sundstedt, Chief Scientific Officer, Idogen AB

Mesenchymal Stem Cells in Clinical Trial for Treatment of Autoimmune Disease
Mathias Svahn, Chief Executive Officer, NextCell Pharma AB

Challenges when Introducing Cell and Gene Therapies
Emmelie Persson, Head Market Access & External Affairs, Novartis Oncology Sweden

Gene Therapy - A Potential Game Changer: Opportunities and Threats
Christoph Varenhorst, Country Medical Director, Pfizer Sweden

Personalized Tissue Engineered Grafts – A Specialty within a Specialty Area
Raimund Strehl, Chief Technology Officer, VeriGraft AB

Developing and Producing MSCs for the Prevention and Treatment of Cartilage Disease
Evy Lundgren-Åkerlund, Chief Executive Officer, Xintela AB

15.30 - 16.00 Break and Refreshments

16.00 - 17.00 Presentation of Swedish ATMP Initiatives and Panel Discussion (in Swedish):

Presentation av initiativ för att stärka utvecklingen av ATMP i Sverige: Centre for Advanced Medical Products och Swelife-ATMP
Mikael Wiberg, Kristina Kannisto, Ann Novotny

Paneldiskussion: Hur kan vi få igång en starkare ATMP-utveckling i Sverige?
Mikael Wiberg, Alexandra Karström, Anders Lindahl, Johan Hyllner, Anna Sandström, Malin Parkler, Agneta Edberg + representanter från Läkemedelsverket, IVO, Socialstyrelsen

17.00 - 17.10 Concluding Remarks

17.10 - 18.00 Networking and Refreshments

18.00 End of Conference


Centre for Advanced Medical Products (CAMP) is a Swedish national center for research, clinical applications, production and commercialization of advanced therapies, for the benefit of patients and industry growth.

Swelife-ATMP is a project aiming to strengthen Sweden´s competitiveness within cell- and gene therapies (read more about the project).

Medicon Village is a science park offering a unique environment for science, integrating research, innovation and enterprise to create value for human health and wellbeing. Read more about Medicon Village...

Organizing committee: Jukka Lausmaa, RISE Research Institutes of Sweden, Kristina Kannisto and Michael Uhlin, Karolinska Universitetssjukhuset, Ann Novotny, Gothia Forum, Kerstin Jakobsson, Medicon Village Science Park.



När: tors, 15 mar 2018 09:00 till 18:00
Var: Medicon Village, Lund
Arrangör: Centre for Advanced Medical Products (CAMP), Swelife and Medicon Village
Språk: Engelska & Svenska